Furthermore, inhibiting HSF1 specifically can reverse the ferroptosis resistance generated by GPX4 suppression and greatly improve the in vitro sensitivity of resistant cancer cells and tumors to ferroptosis (92). Here, GPX4 is linked to cancer.